John L Moran1, Andrew D Bersten, Patricia J Solomon. 1. Department of Intensive Care Medicine, Queen Elizabeth Hospital, 28 Woodville Road, 5011 Woodville, SA, Australia. john.moran@nwahs.sa.gov.au
Abstract
OBJECTIVE: The role of protective ventilation in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is controversial. Evidence was sought from published randomised trials for a consistent treatment effect of protective ventilation and any covariate modification. DESIGN: Meta-analysis of protective ventilation trials in ALI/ARDS and meta-regression of covariates on treatment effect (log odds ratio), with respect to 28-day mortality. Heterogeneity impact on the meta-analysis was assessed by the H statistic (substantial impact, >1.5) and graphical analysis. Five trials with a total of 1,202 patients were considered. MEASUREMENTS AND RESULTS: Average 28-day mortality was 0.40 in the treatment group (protective ventilation, n=605) vs. 0.46 in the control group (control ventilation, n=597). The treatment effect (odds ratio) was: fixed-effects, 0.71 (95% CI 0.56-0.91, p=0.006; heterogeneity, p=0.06) and random effects: 0.80 (95% CI 0.49-1.31, p=0.37). Heterogeneity impact (H statistic=1.50) was adjudged as modest. The treatment effect was significant and (a) favoured protective ventilation for a tidal volume less than 7.7 ml/kg predicted (treatment group) and a mean plateau pressure of 30 cmH(2)O or higher (control group) but was not influenced by plateau pressure 21-30 cmH(2)O (treatment group) and (b) depended upon plateau pressure difference greater than 5-7 cmH(2)O between protective ventilation and standard ventilation. CONCLUSIONS: Overall treatment effect estimate favoured protective ventilation but did not achieve statistical significance. Protective ventilation depended upon threshold levels of tidal volume, plateau pressure, and plateau pressure difference.
OBJECTIVE: The role of protective ventilation in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is controversial. Evidence was sought from published randomised trials for a consistent treatment effect of protective ventilation and any covariate modification. DESIGN: Meta-analysis of protective ventilation trials in ALI/ARDS and meta-regression of covariates on treatment effect (log odds ratio), with respect to 28-day mortality. Heterogeneity impact on the meta-analysis was assessed by the H statistic (substantial impact, >1.5) and graphical analysis. Five trials with a total of 1,202 patients were considered. MEASUREMENTS AND RESULTS: Average 28-day mortality was 0.40 in the treatment group (protective ventilation, n=605) vs. 0.46 in the control group (control ventilation, n=597). The treatment effect (odds ratio) was: fixed-effects, 0.71 (95% CI 0.56-0.91, p=0.006; heterogeneity, p=0.06) and random effects: 0.80 (95% CI 0.49-1.31, p=0.37). Heterogeneity impact (H statistic=1.50) was adjudged as modest. The treatment effect was significant and (a) favoured protective ventilation for a tidal volume less than 7.7 ml/kg predicted (treatment group) and a mean plateau pressure of 30 cmH(2)O or higher (control group) but was not influenced by plateau pressure 21-30 cmH(2)O (treatment group) and (b) depended upon plateau pressure difference greater than 5-7 cmH(2)O between protective ventilation and standard ventilation. CONCLUSIONS: Overall treatment effect estimate favoured protective ventilation but did not achieve statistical significance. Protective ventilation depended upon threshold levels of tidal volume, plateau pressure, and plateau pressure difference.
Authors: Peter Q Eichacker; Eric P Gerstenberger; Steven M Banks; Xizhong Cui; Charles Natanson Journal: Am J Respir Crit Care Med Date: 2002-08-28 Impact factor: 21.405
Authors: M B Amato; C S Barbas; D M Medeiros; R B Magaldi; G P Schettino; G Lorenzi-Filho; R A Kairalla; D Deheinzelin; C Munoz; R Oliveira; T Y Takagaki; C R Carvalho Journal: N Engl J Med Date: 1998-02-05 Impact factor: 91.245
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Daniel de Backer; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker Journal: Intensive Care Med Date: 2006-02-01 Impact factor: 17.440
Authors: Andrew J Stoltze; Terrence S Wong; Karisa K Harland; Azeemuddin Ahmed; Brian M Fuller; Nicholas M Mohr Journal: J Crit Care Date: 2015-03-03 Impact factor: 3.425
Authors: Karen E A Burns; Neill K J Adhikari; Arthur S Slutsky; Gordon H Guyatt; Jesus Villar; Haibo Zhang; Qi Zhou; Deborah J Cook; Thomas E Stewart; Maureen O Meade Journal: PLoS One Date: 2011-01-28 Impact factor: 3.240
Authors: Marc Licker; Alexandre Schweizer; Christoph Ellenberger; Jean-Marie Tschopp; John Diaper; François Clergue Journal: Int J Chron Obstruct Pulmon Dis Date: 2007